PMTCT_20120302-rus

111.Lambert J et al. Therapeutic drug monitoring of lopinavir/ritonavir in pregnancy. HIV Medicine, 2011, 12(3):166–173.

112.Mirochnick M et al. Lopinavir exposure with an increased dose during pregnancy. Journal of Acquired Immune Deficiency Syndromes, 2008, 49(5):485–491.

113.Taylor GP et al. Comparison of total and unbound lopinavir (LPV) pharmacokinetics (PK) in HIVinfected pregnant women receiving lopinavir/ritonavir (LPV/r) soft gel capsules or tablets. 18th International AIDS Conference, Vienna, 18–23 July 2010.

114.Aweeka F et al. Lopinavir protein binding in HIV-1 infected pregnant women. HIV Medicine, 2010, 11:232–238.

115.Samuel MAtazanavir in pregnancy: a report of 155 cases. HIV Medicine, 2011, 12[Suppl 1].

116.Ripamonti D et al.Atazanavir plus low-dose ritonavir in pregnancy: pharmacokinetics and placental transfer. AIDS, 2007, 21(18):2409–2415.

117.Mirochnick M et al. Atazanavir pharmacokinetics with and without tenofovir during pregnancy.

Journal of Acquired Immune Deficiency Syndromes, 2011, January.

118.Cance-Katz EF et al. Interactions between buprenorphine and antiretrovirals. II. The protease inhibitors nelfinavir, lopinavir/ritonavir, and ritonavir. Clinical Infectious Diseases, 2006, 43 Suppl 4:S235–S246.

119.Stevens RC Lack of methadone dose alterations or withdrawal symptoms during therapy with lopinavir/ritonavir. Journal of Acquired Immune Deficiency Syndromes, 2003, 33(5):650–651.

120.Pinnetti C et al. Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancy. Journal of Antimicrobials and Chemotherapy, 2010, 65(9):2050–2052.

121.Colbers A et al. A comparison of the pharmacokinetics of raltegravir during pregnancy and postpartum. 12th International Workshop on Clinical Pharmacology of HIV Therapy, 13–15 April 2001, Miami.

122.HIV and Infant Feeding: A guide for health care managers and supervisors. Geneva, World Health Organization, 2003.

123.Finnegan LP. Neonatal abstinence syndrome: assessment and pharmacotherapy. In: Nelson N, editor.

Current therapy in neonatal-perinatal medicine, 2nd ed. Hamilton, Ontario, BC Decker, 1990.

62